Amedisys Inc. (AMED)

152.85
NASDAQ : Health Services
Prev Close 151.26
Day Low/High 150.47 / 153.51
52 Wk Low/High 103.76 / 154.14
Avg Volume 261.50K
Exchange NASDAQ
Shares Outstanding 32.26M
Market Cap 4.88B
EPS 3.60
P/E Ratio 39.29
Div & Yield N.A. (N.A)

Latest News

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."

Here's What Blackstone and KKR Are Buying

Here's What Blackstone and KKR Are Buying

Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.

Blackstone, KKR Unveil Second-Quarter Stock Picks

Blackstone, KKR Unveil Second-Quarter Stock Picks

Food and health care companies were among the top stocks chosen in the quarter by the top PE firms.

Blackstone and KKR Unveil Stock Picks Despite Bearish Tone Among Private-Equity Players

Blackstone and KKR Unveil Stock Picks Despite Bearish Tone Among Private-Equity Players

It's apparently not all doom and gloom in the private-equity realm of stock picking these days.

Amedisys upgraded at Oppenheimer

Where to Get Started Investing in End-of-Life Services

Where to Get Started Investing in End-of-Life Services

It's one of those things people are going to need regardless of the economy.

Obamacare, Technology Boosting Home Health Business Says Amedisys CEO

Obamacare, Technology Boosting Home Health Business Says Amedisys CEO

Shares of home health and hospice care provider Amedisys are up over 50% so far in 2015.

Amedisys upgraded at Jefferies

Amedisys upgraded at Deutsche

Revisiting a Touchy Subject

Revisiting a Touchy Subject

A second look at three companies that provide end-of-life care.

Investing in a Touchy Subject

Investing in a Touchy Subject

Companies that provide end-of-life services have demographics on their side.

Amedisys numbers raised at Jefferies

Amedisys numbers lowered at Jefferies

A Cure for What Ails Us

A Cure for What Ails Us

These stocks stand to benefit if Americans can accept the fact that rising health care costs aren't magically going away.

Amedisys numbers raised at Jefferies

The Insurance Contagion

Financial pain caused by a flat yield curve will cascade from the insurance industry into health care.